Polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) affects 5–18% of women, and is a reproductive,
metabolic, and psychological condition with impacts across the lifespan. The cause is …
metabolic, and psychological condition with impacts across the lifespan. The cause is …
[HTML][HTML] Metformin: Is it a drug for all reasons and diseases?
CR Triggle, I Mohammed, K Bshesh, I Marei, K Ye… - Metabolism, 2022 - Elsevier
Metformin was first used to treat type 2 diabetes in the late 1950s and in 2022 remains the
first-choice drug used daily by approximately 150 million people. An accumulation of …
first-choice drug used daily by approximately 150 million people. An accumulation of …
Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
V Wekker, L Van Dammen, A Koning… - Human reproduction …, 2020 - academic.oup.com
BACKGROUND Polycystic ovary syndrome (PCOS) is associated with cardiometabolic
disease, but recent systematic reviews and meta-analyses of longitudinal studies that …
disease, but recent systematic reviews and meta-analyses of longitudinal studies that …
[HTML][HTML] The crucial role and mechanism of insulin resistance in metabolic disease
X Zhao, X An, C Yang, W Sun, H Ji… - Frontiers in endocrinology, 2023 - frontiersin.org
Insulin resistance (IR) plays a crucial role in the development and progression of
metabolism-related diseases such as diabetes, hypertension, tumors, and nonalcoholic fatty …
metabolism-related diseases such as diabetes, hypertension, tumors, and nonalcoholic fatty …
Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls
SF Witchel, SE Oberfield, AS Peña - Journal of the Endocrine …, 2019 - academic.oup.com
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by
hyperandrogenism and chronic anovulation. Depending on diagnostic criteria, 6% to 20% of …
hyperandrogenism and chronic anovulation. Depending on diagnostic criteria, 6% to 20% of …
[HTML][HTML] Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention
Although polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders
affecting women, its etiology is not entirely understood. Clinical symptoms of PCOS include …
affecting women, its etiology is not entirely understood. Clinical symptoms of PCOS include …
[HTML][HTML] Lifestyle management in polycystic ovary syndrome–beyond diet and physical activity
Polycystic ovary syndrome (PCOS) is a common condition affecting reproductive-aged
women with reproductive, metabolic and psychological consequences. Weight and lifestyle …
women with reproductive, metabolic and psychological consequences. Weight and lifestyle …
Polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) affects 5–20% of women of reproductive age worldwide.
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …
The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited
RL Rosenfield, DA Ehrmann - Endocrine reviews, 2016 - academic.oup.com
Polycystic ovary syndrome (PCOS) was hypothesized to result from functional ovarian
hyperandrogenism (FOH) due to dysregulation of androgen secretion in 1989–1995 …
hyperandrogenism (FOH) due to dysregulation of androgen secretion in 1989–1995 …
The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance
BACKGROUND Here we describe the consensus guideline methodology, summarise the
evidence-based recommendations we provided to the World Health Organisation (WHO) for …
evidence-based recommendations we provided to the World Health Organisation (WHO) for …